$12.3 M

ETBI Mkt cap, 08-Jan-2020

$23.1 K

EastGate Biotech Revenue Q3, 2017
EastGate Biotech Gross profit (Q3, 2017)-69.2 K
EastGate Biotech Gross profit margin (Q3, 2017), %(299.1%)
EastGate Biotech Net income (Q3, 2017)-1.6 M
EastGate Biotech EBIT (Q3, 2017)-1.7 M
EastGate Biotech Cash, 30-Sept-20174.9 K
EastGate Biotech EV13 M

EastGate Biotech Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

132.0k

Cost of goods sold

19.2k

Gross profit

112.8k

Gross profit Margin, %

85%

Sales and marketing expense

25.6k76.2k487.4k271.9k

R&D expense

105.4k132.1k840.2k1.1m501.8k

General and administrative expense

23.9k383.5k1.4m3.7m2.5m1.8m

Operating expense total

23.9k488.9k1.6m4.6m4.3m2.6m

EBIT

(23.9k)(605.8k)(1.7m)(4.8m)(4.2m)(2.6m)

EBIT margin, %

(3160%)

Interest expense

6.0k17.0k64.2k88.9k109.9k344.0k

Pre tax profit

(29.9k)(622.8k)(1.7m)(4.9m)(4.3m)(3.0m)

Net Income

(29.9k)(622.8k)(1.7m)(4.9m)(4.3m)(3.0m)

EastGate Biotech Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

100.0k458.0286.5k19.2k

Prepaid Expenses

4.5k

Current Assets

104.5k458.0339.7k113.5k

PP&E

71.3k143.2k184.4k

Total Assets

104.5k71.8k482.9k297.9k

Accounts Payable

421.4k299.1k361.1k279.7k

Short-term debt

8.1k10.4k

Current Liabilities

89.2k713.5k2.4m1.9m2.7m4.6m

Long-term debt

50.4k40.0k

Non-Current Liabilities

50.4k

Total Debt

58.5k50.4k

Total Liabilities

1.9m2.8m4.6m

Common Stock

116.031.6m316.0896.02.8k3.1k

Additional Paid-in Capital

32.1k134.9k134.9k6.0m9.1m10.0m

Retained Earnings

(121.4k)(744.2k)(11.7m)(14.6m)

Total Equity

(89.2k)(609.0k)(2.3m)(1.4m)(2.5m)(4.6m)

Financial Leverage

-0.2 x0 x-0.3 x-0.1 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

10.9k1.8k26.4k784.0k375.3k6.2k28.9k10.8k72.5k9.3k78.6k4.9k

Accounts Receivable

36.0k868.3k28.7k

Prepaid Expenses

4.5k21.7k

Inventories

112.9k

Current Assets

15.4k1.8k26.4k784.0k375.3k46.4k104.2k81.1k166.8k10.8k607.2k349.4k9.3k946.8k168.3k

PP&E

64.2k60.9k57.7k67.0k125.0k148.5k134.0k124.7k198.0k157.3k143.7k701.8k

Total Assets

79.6k62.7k101.8k865.8k529.1k235.4k238.2k205.7k364.7k10.8k764.5k493.2k9.3k1.8m1.7m

Accounts Payable

346.4k419.0k258.0k249.2k248.7k289.6k337.3k337.4k269.2k380.5k367.2k423.7k462.4k706.1k

Short-term debt

39.7k40.6k34.4k3.6k7.6k8.7k8.5k10.1k80.8k731.3k694.8k

Current Liabilities

75.0k79.3k94.9k218.1k383.8k841.0k1.1m1.3m1.5m1.4m1.9m2.0m2.1m2.1m3.2m3.8m4.2m4.9m5.8m7.0m

Long-term debt

14.1k3.6k52.7k47.8k48.1k41.4k40.0k

Non-Current Liabilities

52.7k40.0k

Total Debt

53.8k44.2k34.4k3.6k60.3k56.5k56.5k51.5k120.8k731.3k694.8k

Total Liabilities

855.1k1.1m1.4m1.9m2.0m2.1m2.2m3.2m3.8m4.3m4.9m5.8m7.0m

Common Stock

15.015.0116.0316.0316.0316.0316.0316.0433.0498.0525.01.3k2.0k2.9k3.1k3.1k3.1k3.3k11.4k11.3k

Preferred Stock

200.0

Additional Paid-in Capital

29.2k30.7k33.6k134.9k134.9k134.9k134.9k134.9k2.8m4.4m4.6m7.4m8.1m9.0m9.9m9.9m9.9m10.6m12.2m13.2m

Retained Earnings

(10.0m)(10.8m)(13.1m)(13.0m)(13.7m)(15.6m)(16.3m)(18.4m)

Total Equity

(75.0k)(79.3k)(94.9k)(218.1k)(383.8k)(775.5k)(1.0m)(1.2m)(667.3k)(910.7k)(1.7m)(1.7m)(1.9m)(1.8m)(3.2m)(3.1m)(3.8m)(4.9m)(4.0m)(5.3m)

Debt to Equity Ratio

0 x0 x0 x

Debt to Assets Ratio

5.2 x0.1 x0.1 x

Financial Leverage

-0.1 x-0.1 x-0.1 x-1.3 x-0.6 x-0.1 x-0.1 x-0.1 x-0.2 x0 x-0.2 x-0.1 x0 x-0.4 x-0.3 x

EastGate Biotech Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(29.9k)(622.8k)(1.7m)(4.9m)(4.3m)(3.0m)

Depreciation and Amortization

14.5k27.9k44.2k

Accounts Payable

11.4k216.8k192.2k47.4k100.0k18.9k

Cash From Operating Activities

(407.7k)(1.2m)(568.4k)(389.5k)

Purchases of PP&E

(99.8k)

Cash From Investing Activities

(22.3k)(99.8k)

Short-term Borrowings

(87.5k)(3.2k)

Long-term Borrowings

(24.4k)(5.9k)(8.1k)

Cash From Financing Activities

100.0k330.3k1.6m326.7k321.6k

Net Change in Cash

100.0k(99.7k)282.1k(241.7k)(67.9k)

Interest Paid

4.4k1.2k4.9k13.4k

EastGate Biotech Ratios

USDY, 2017

EV/EBIT

-7.7 x

EV/CFO

-8.2 x

Financial Leverage

-0.3 x